Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Codeine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 known ✓ | P41143 | 9/20 | 0.98 |
| ▸ | OPRM1 known ✓ | P35372 | 7/20 | 0.98 |
| ▸ | OPRK1 known ✓ | P41145 | 5/20 | 0.98 |
| ▸ | MRGPRX2 | Q96LB1 | 4/20 | 0.98 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.98 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.98 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.98 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.74 |
| ▸ | ARRB1 | P49407 | 1/20 | 0.74 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Codeine SCHEMBL548093 | 1.00 | OPRD1 (0.98) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL9324126 | 0.99 | OPRM1 (0.98) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL1276342 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL8218174 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL12638890 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL1560699 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL13696342 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL14371354 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL21077535 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL3257 | 0.99 | OPRD1 (1.00) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106265493-A | Improve the pharmaceutical composition of Codeine Hydrochloride drug injection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2017-01-04 | — | — | CN | claimed |
| CN-106176588-A | Improve the preparation method of composition of Codeine Hydrochloride ejection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-101474148-B | Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof | Shenzhen zhijun pharmaceutical co ltd | 2012-11-14 | — | — | CN | claimed |
| CN-101474148-A | Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof | SHENZHEN ZHIJUN PHARMACEUTICAL (CN) | 2009-07-08 | — | — | CN | claimed |
| EP-2043613-A1 | SOLID FORM | FMC CORPORATION (US) | 2009-04-08 | — | — | EP | claimed |
| US-20080311162-A1 | Solid form | FMC CORPORATION | 2008-12-18 | — | — | US | claimed |
| US-20080286343-A1 | Solid form | FMC CORPORATION | 2008-11-20 | — | — | US | claimed |
| WO-2008140459-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | claimed |
| WO-2008140460-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | claimed |
| WO-2008140461-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | claimed |
| US-20080286344-A1 | Solid form | FMC CORPORATION | 2008-11-20 | — | — | US | claimed |
| CN-100369607-C | Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method | SHENZHEN CITY PHARMACEUTICAL F (CN) | 2008-02-20 | — | — | CN | claimed |
| WO-2008008120-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-01-17 | — | — | WO | claimed |
| US-20080014228-A1 | Solid form | FMC CORPORATION | 2008-01-17 | — | — | US | claimed |
| CN-1820752-A | Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method | SHENZHEN CITY PHARMACEUTICAL F (CN) | 2006-08-23 | — | — | CN | claimed |
| US-20050048164-A1 | Chewing gum core overcoated with active powder materials containing anseptics, cooling compound, flavor intensifier, sweetening , enzyme, drug | STAHL BRONISLAW-JAN (DK) | 2005-03-03 | — | — | US | claimed |
| EP-1495681-A2 | A coated chewing gum, a method for preparation thereof and the use of one or more active substances in the coating | DANDY A/S (DK) | 2005-01-12 | — | — | EP | claimed |
| CN-1042598-C | Antitussive and expectorant preparation consisting of codeine and root of ballon flower | QINGHAI PHARMACEUTICAL PLANT (CN) | 1999-03-24 | — | — | CN | claimed |
| CN-1088799-A | The relieving cough and expelling phlegm agent that codeine Radix Platycodonis is formed | QINGHAI PHARMACEUTIC PLANT (CN) | 1994-07-06 | — | — | CN | claimed |
| US-20260144746-A1 | Protein Based Soft Chew Tablets | FERTIN PHARMA A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| US-20260144745-A1 | Sugar Free Soft Chew Tablets | FERTIN PHARMA A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| EP-4734952-A1 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | Fertin Pharma A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| US-12551439-B2 | Flowpack for oral delivery of active ingredients | FERTIN PHARMA A/S (DK) | 2026-02-17 | — | — | US | disclosed |
| US-20250325483-A1 | FLOWPACK WITH COMPOSITION FOR IMPROVED TASTE MASKING OF ACTIVES | FERTIN PHARMA AS (DK) | 2025-10-23 | — | — | US | disclosed |
| US-20250281680-A1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | BIOSAPIEN INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | Didenko, Kirill (US) | 2025-07-03 | — | — | US | disclosed |
| US-20250177290-A1 | DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF | BioSapien Inc. | 2025-06-05 | — | — | US | disclosed |
| US-20250177308-A1 | Oral Powder Mixture With Small Sized Particles | FERTIN PHARMA A/S (DK) | 2025-06-05 | — | — | US | disclosed |
| CN-114729004-B | Heterocyclic compounds | 日商泛美克斯股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025108529-A1 | SOFT CHEW TABLETS SUITABLE FOR ANTACIDS | FERTIN PHARMA A/S (DK) | 2025-05-30 | — | — | WO | disclosed |
| US-20250170056-A1 | Soft Chew Tablets Suitable For Antacids | FERTIN PHARMA A/S (DK) | 2025-05-29 | — | — | US | disclosed |
| EP-4547226-A1 | FLOWPACK WITH COMPOSITION FOR IMPROVED TASTE MASKING OF ACTIVES | Fertin Pharma A/S (DK) | 2025-05-07 | — | — | EP | disclosed |
| EP-3793520-B1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE THROAT COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-04-30 | — | — | EP | disclosed |
| EP-4146164-B1 | FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS | FERTIN PHARMA AS (DK) | 2025-04-30 | — | — | EP | disclosed |
| EP-3793518-B1 | AN ORAL TABLET FOR TASTE MASKING OF ACTIVE INGREDIENTS COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-03-26 | — | — | EP | disclosed |
| US-12257346-B2 | Oral powder mixture with small sized particles | FERTIN PHARMA A/S (DK) | 2025-03-25 | — | — | US | disclosed |
| EP-4522238-A2 | DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF | Biosapien Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119546355-A | Drug eluting surgical article and method of use | 生物智慧公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-115380006-B | Method for producing free-flowing granulates | 欧米亚国际集团 | 2025-02-28 | — | — | CN | disclosed |
| US-20250009663-A1 | Mouthwash For Oral Care Benefits | FERTIN PHARMA A/S (DK) | 2025-01-09 | — | — | US | disclosed |
| US-20250000820-A1 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | FERTIN PHARMA A/S (DK) | 2025-01-02 | — | — | US | disclosed |
| WO-2025002519-A1 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | FERTIN PHARMA A/S (DK) | 2025-01-02 | — | — | WO | disclosed |
| US-20240415775-A1 | Multi-Layered Dextrose Tablets | FERTIN PHARMA A/S (DK) | 2024-12-19 | — | — | US | disclosed |
| US-12156943-B2 | Tablet dosage form for buccal absorption of active ingredients | FERTIN PHARMA A/S (DK) | 2024-12-03 | — | — | US | disclosed |
| US-12128138-B2 | Mouthwash for oral care benefits | FERTIN PHARMA A/S (DK) | 2024-10-29 | — | — | US | disclosed |
| EP-4088716-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2024-10-16 | — | — | EP | disclosed |
| US-12109312-B2 | Oral tablet for taste masking of active ingredients | FERTIN PHARMA A/S (DK) | 2024-10-08 | — | — | US | disclosed |
| US-12102714-B2 | Disintegrating oral tablet suitable for active pharmaceutical ingredients | FERTIN PHARMA A/S (DK) | 2024-10-01 | — | — | US | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| CN-118593436-A | High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate | OMYA国际股份公司 | 2024-09-06 | — | — | CN | disclosed |
| EP-3899995-B1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | BIOSAPIEN INC (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4415686-A1 | DEXTROSE TABLETS WITH IMPROVED MOUTHFEEL | Fertin Pharma A/S (DK) | 2024-08-21 | — | — | EP | disclosed |
| EP-4415687-A1 | MULTI-LAYERED DEXTROSE TABLETS | Fertin Pharma A/S (DK) | 2024-08-21 | — | — | EP | disclosed |
| CN-112153964-B | Oral tablets suitable for active pharmaceutical ingredient comprising non-directly compressible sugar alcohol particles | 费尔廷制药公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118103029-A | Dextrose tablet with improved mouthfeel | 费尔廷制药公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118103028-A | Multilayer dextrose tablet | 费尔廷制药公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11969527-B2 | Drug-eluting biomaterials and related methods | BioSapien Inc. (US) | 2024-04-30 | — | — | US | disclosed |
| CN-117794861-A | Process for producing pellets comprising magnesium ion containing material | OMYA国际股份公司 | 2024-03-29 | — | — | CN | disclosed |
| US-11883458-B2 | Herb medicine composition for alleviating or treating asthma, and oriental pharmacopuncture solution containing same and injection containing same | KIM SUNG KI (KR) | 2024-01-30 | — | — | US | disclosed |
| WO-2024002447-A1 | FLOWPACK WITH COMPOSITION FOR IMPROVED TASTE MASKING OF ACTIVES | FERTIN PHARMA A/S (DK) | 2024-01-04 | — | — | WO | disclosed |
| CN-112118834-B | Oral tablet for inducing saliva production | 费尔廷制药公司 | 2024-01-02 | — | — | CN | disclosed |
| EP-3597262-B1 | FORMULATION FOR INTRACUTANEOUS INJECTION | XERIS PHARMACEUTICALS INC (US) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023220400-A2 | DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF | BioSapien Inc. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-114588124-B | Delayed release pharmaceutical composition | 江苏恒瑞医药股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023187599-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | DIDENKO KIRILL (MX) | 2023-10-05 | — | — | WO | disclosed |
| EP-2312933-B1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | TASMANIAN ALKALOIDS PTY LTD (AU) | 2023-09-20 | — | — | EP | disclosed |
| CN-113632188-B | Drug eluting surgical articles and related methods | 生物智慧公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-3793533-B1 | A TABLET DOSAGE FORM FOR BUCCAL ABSORPTION OF ACTIVE INGREDIENTS | FERTIN PHARMA AS (DK) | 2023-07-05 | — | — | EP | disclosed |
| EP-3787604-B1 | A TABLETED CHEWING GUM SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | FERTIN PHARMA AS (DK) | 2023-07-05 | — | — | EP | disclosed |
| CN-116262744-A | Small molecule probes for alpha-synuclein aggregate imaging | 复旦大学 | 2023-06-16 | — | — | CN | disclosed |
| CN-116251199-A | Small molecule probes that bind to alpha-synuclein aggregates and uses thereof | 复旦大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-116199622-A | Small molecule binding ligands for alpha-synuclein aggregates and uses thereof | 复旦大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-112118831-B | Tabletted chewing gum sweet suitable for active pharmaceutical ingredient | 费尔廷制药公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-112118832-B | Buccal tablet dosage form for active ingredient | 费尔廷制药公司 | 2023-04-21 | — | — | CN | disclosed |
| WO-2023061543-A1 | DEXTROSE TABLETS WITH IMPROVED MOUTHFEEL | FERTIN PHARMA A/S (DK) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023061544-A1 | MULTI-LAYERED DEXTROSE TABLETS | FERTIN PHARMA A/S (DK) | 2023-04-20 | — | — | WO | disclosed |
| US-20230123099-A1 | DEXTROSE TABLETS WITH IMPROVED MOUTHFEEL | FERTIN PHARMA A/S (DK) | 2023-04-20 | — | — | US | disclosed |
| EP-3793534-B1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT | FERTIN PHARMA AS (DK) | 2023-04-05 | — | — | EP | disclosed |
| EP-4146164-A1 | FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS | Fertin Pharma A/S (DK) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146165-A1 | ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLES | Fertin Pharma A/S (DK) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146166-A1 | MOUTHWASH FOR ORAL CARE BENEFITS | Fertin Pharma A/S (DK) | 2023-03-15 | — | — | EP | disclosed |
| CN-115768403-A | Mouthwash for oral care benefits | 费尔廷制药公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-112118833-B | Disintegrating oral tablets suitable for active pharmaceutical ingredients | 费尔廷制药公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-115515562-A | Oral powder mixture with small size particles | 费尔廷制药公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115515563-A | Compression molded packaging for oral delivery of active ingredients | 费尔廷制药公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-109963553-B | Oral delivery vehicle | 费尔廷制药公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-4088716-A1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | Fertin Pharma A/S (DK) | 2022-11-16 | — | — | EP | disclosed |
| US-11484503-B2 | Tablet comprising separate binder and erythritol | FERTIN PHARMA A/S (DK) | 2022-11-01 | — | — | US | disclosed |
| CN-109952092-B | Tablet comprising separate binder and erythritol | 费尔廷制药公司 | 2022-08-23 | — | — | CN | disclosed |
| US-20220249589-A1 | HERB MEDICINE COMPOSITION FOR ALLEVIATING OR TREATING ASTHMA, AND ORIENTAL PHARMACOPUNCTURE SOLUTION CONTAINING SAME AND INJECTION CONTAINING SAME | KIM SUNG KI (KR) | 2022-08-11 | — | — | US | disclosed |
| EP-3773511-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2022-07-06 | — | — | EP | disclosed |
| CN-114588124-A | Delayed release pharmaceutical composition | 江苏恒瑞医药股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11351162-B2 | Oral delivery vehicle containing flavoring agents | FERTIN PHARMA A/S (DK) | 2022-06-07 | — | — | US | disclosed |
| EP-3324975-B1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | HSU JOHN (US) | 2022-05-18 | — | — | EP | disclosed |
| US-11260030-B2 | Oral tablet for delivery of active ingredients to the gastrointestinal tract | FERTIN PHARMA A/S (DK) | 2022-03-01 | — | — | US | disclosed |
| US-20210379251-A1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | BioSapien Inc. | 2021-12-09 | — | — | US | disclosed |
| US-20210346263-A1 | Mouthwash For Oral Care Benefits | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | US | disclosed |
| US-20210346257-A1 | Oral Powder Mixture With Small Sized Particles | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | US | disclosed |
| US-20210346295-A1 | FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | US | disclosed |
| WO-2021223824-A1 | FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021223825-A1 | ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLES | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021223826-A1 | MOUTHWASH FOR ORAL CARE BENEFITS | FERTIN PHARMA A/S (DK) | 2021-11-11 | — | — | WO | disclosed |
| CN-113632188-A | Drug eluting surgical articles and related methods | 生物智慧公司 | 2021-11-09 | — | — | CN | disclosed |
| EP-3899995-A1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | Biosapien Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| US-11135157-B2 | Oral tablet for delivery of active ingredients to the throat | FERTIN PHARMA A/S (DK) | 2021-10-05 | — | — | US | disclosed |
| US-11135156-B2 | Pharmaceutical tablet for use in administering one or more pharmaceutically active ingredients | FERTIN PHARMA A/S (DK) | 2021-10-05 | — | — | US | disclosed |
| US-20210299052-A1 | Oral Tablet For Delivery Of Active Ingredients To The Gastrointestinal Tract | FERTIN PHARMA A/S (DK) | 2021-09-30 | — | — | US | disclosed |
| US-20210290547-A1 | Oral Tablet For Taste Masking Of Active Ingredients | FERTIN PHARMA A/S (DK) | 2021-09-23 | — | — | US | disclosed |
| US-20210290530-A1 | Disintegrating Oral Tablet Suitable For Active Pharmaceutical Ingredients | FERTIN PHARMA A/S (DK) | 2021-09-23 | — | — | US | disclosed |
| US-11090263-B2 | Tableted chewing gum suitable for active pharmaceutical ingredients | FERTIN PHARMA A/S (DK) | 2021-08-17 | — | — | US | disclosed |
| US-20210244742-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | HSU JOHN (US) | 2021-08-12 | — | — | US | disclosed |
| EP-3854383-A1 | ORAL DELIVERY VEHICLE | Fertin Pharma A/S (DK) | 2021-07-28 | — | — | EP | disclosed |
| US-11058633-B2 | Disintegrating oral tablet suitable for active pharmaceutical ingredients | FERTIN PHARMA A/S (DK) | 2021-07-13 | — | — | US | disclosed |
| US-11058641-B2 | Oral tablet for taste masking of active ingredients | FERTIN PHARMA A/S (DK) | 2021-07-13 | — | — | US | disclosed |
| US-11052047-B2 | Oral tablet suitable for fast release of active pharmaceutical ingredients | FERTIN PHARMA A/S (DK) | 2021-07-06 | — | — | US | disclosed |
| US-20210169808-A1 | Tablet Dosage Form For Buccal Absorption Of Active Ingredients | FERTIN PHARMA A/S (DK) | 2021-06-10 | — | — | US | disclosed |
| EP-2928681-B1 | COMPRESSED TABLETS | FERTIN PHARMA AS (DK) | 2021-06-09 | — | — | EP | disclosed |
| US-20210106534-A1 | Disintegrating Oral Tablet Suitable For Active Pharmaceutical Ingredients | FERTIN PHARMA A/S (DK) | 2021-04-15 | — | — | US | disclosed |
| EP-3541357-B1 | ORAL DELIVERY VEHICLE | FERTIN PHARMA AS (DK) | 2021-04-14 | — | — | EP | disclosed |
| EP-3801545-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | Hsu, John (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-3793534-A1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793531-A1 | DISINTEGRATING ORAL TABLET SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793518-A1 | AN ORAL TABLET FOR TASTE MASKING OF ACTIVE INGREDIENTS COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793532-A1 | AN ORAL TABLET SUITABLE FOR FAST RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793533-A1 | A TABLET DOSAGE FORM FOR BUCCAL ABSORPTION OF ACTIVE INGREDIENTS | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793519-A1 | AN ORAL TABLET SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3793520-A1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE THROAT COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | Fertin Pharma A/S (DK) | 2021-03-24 | — | — | EP | disclosed |
| EP-3787604-A1 | A TABLETED CHEWING GUM SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Fertin Pharma A/S (DK) | 2021-03-10 | — | — | EP | disclosed |
| US-10926005-B2 | Drug-eluting surgical articles with a plurality of geometric elements | BioSapien Inc. (US) | 2021-02-23 | — | — | US | disclosed |
| EP-3773511-A1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | Fertin Pharma A/S (DK) | 2021-02-17 | — | — | EP | disclosed |
| EP-3541359-B1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA AS (DK) | 2021-01-27 | — | — | EP | disclosed |
| CN-112218624-A | Oral tablet for delivering active ingredients to the gastrointestinal tract | 费尔廷制药公司 | 2021-01-12 | — | — | CN | disclosed |
| US-20210000061-A1 | A Plant of Papaver Somniferum With An Altered Alkaloid Profile | TASMANIAN ALKALOIDS PTY LTD (AU) | 2021-01-07 | — | — | US | disclosed |
| EP-3758728-A1 | A PLANT OF PAPAVER SOMNIFERUM WITH AN ALTERED ALKALOID PROFILE | Tasmanian Alkaloids Pty. Ltd. (AU) | 2021-01-06 | — | — | EP | disclosed |
| CN-112153964-A | Oral tablet suitable for active pharmaceutical ingredients comprising non-directly compressible sugar alcohol particles | 费尔廷制药公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-112118831-A | Tabletted chewing gum suitable for active pharmaceutical ingredients | 费尔廷制药公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-112118833-A | Disintegrating oral tablets suitable for active pharmaceutical ingredients | 费尔廷制药公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-112118834-A | Oral tablet for inducing saliva production | 费尔廷制药公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-112118832-A | Tablet dosage form for buccal absorption of active ingredients | 费尔廷制药公司 | 2020-12-22 | — | — | CN | disclosed |
| US-20200384163-A1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | BioSapien Inc. | 2020-12-10 | — | — | US | disclosed |
| US-10791691-B2 | Papaver somniferum with high concentration of codeine | TASMANIAN ALKALOIDS PTY. LTD. (AU) | 2020-10-06 | — | — | US | disclosed |
| WO-2020132569-A1 | DRUG-ELUTING SURGICAL ARTICLES AND RELATED METHODS | BioSapien Inc. (US) | 2020-06-25 | — | — | WO | disclosed |
| CN-107397738-B | Compound pharmaceutical composition with cough and asthma relieving effect and application thereof | 佛山市第五人民医院 | 2020-06-05 | — | — | CN | disclosed |
| US-10653700-B2 | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | HSU JOHN (US) | 2020-05-19 | — | — | US | disclosed |
| US-10632076-B2 | Tablet comprising separate binder and erythritol | FERTIN PHARMA A/S (DK) | 2020-04-28 | — | — | US | disclosed |
| US-20200108058-A1 | Compressed Tablets | FERTIN PHARMA A/S (DK) | 2020-04-09 | — | — | US | disclosed |
| CN-107021946-B | Compound with cough relieving effect and preparation and application thereof | 中山火炬职业技术学院 | 2020-04-03 | — | — | CN | disclosed |
| US-20200078308-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2020-03-12 | — | — | US | disclosed |
| US-20200078349-A1 | ORAL DELIVERY VEHICLE CONTAINING NICOTINE | FERTIN PHARMA A/S (DK) | 2020-03-12 | — | — | US | disclosed |
| US-10543205-B2 | Oral delivery vehicle containing nicotine | FERTIN PHARMA A/S (DK) | 2020-01-28 | — | — | US | disclosed |
| CN-110585200-A | Compound pharmaceutical composition with cough and asthma relieving effect and application thereof | 郴州市第一人民医院 | 2019-12-20 | — | — | CN | disclosed |
| US-20190350857-A1 | ORAL TABLET FOR TASTE MASKING OF ACTIVE INGREDIENTS | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350860-A1 | Oral Tablet Suitable For Active Pharmaceutical Ingredients | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350847-A1 | DISINTEGRATING ORAL TABLET SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350848-A1 | ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE THROAT | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350859-A1 | Oral Tablet For Induced Saliva Generation | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350861-A1 | Tablet Dosage Form For Buccal Absorption Of Active Ingredients | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350862-A1 | ORAL TABLET SUITABLE FOR FAST RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| US-20190350858-A1 | ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT | FERTIN PHARMA A/S (DK) | 2019-11-21 | — | — | US | disclosed |
| EP-3541357-A1 | ORAL DELIVERY VEHICLE | Fertin Pharma A/S (DK) | 2019-09-25 | — | — | EP | disclosed |
| EP-3541359-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | Fertin Pharma A/S (DK) | 2019-09-25 | — | — | EP | disclosed |
| EP-2526996-B1 | Formulation for intracutaneous injection | XERIS PHARMACEUTICALS INC (US) | 2019-09-11 | — | — | EP | disclosed |
| US-10391054-B2 | Pharmaceutical tablet for use in administering nicotine | FERTIN PHARMA A/S (DK) | 2019-08-27 | — | — | US | disclosed |
| US-20190209551-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC (US) | 2019-07-11 | — | — | US | disclosed |
| EP-3506736-A1 | P. SOMNIFERUM PLANTS FOR THE PRODUCTION OF CODEINE | Tasmanian Alkaloids Pty. Ltd. (AU) | 2019-07-10 | — | — | EP | disclosed |
| CN-109963553-A | Oral delivery carrier | 费尔廷制药公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-109952092-A | Tablet comprising independent binder and antierythrite | 费尔廷制药公司 | 2019-06-28 | — | — | CN | disclosed |
| US-20190185869-A1 | P. SOMNIFERUM PLANTS FOR THE PRODUCTION OF CODEINE | TASMANIAN ALKALOIDS PTY LTD (AU) | 2019-06-20 | — | — | US | disclosed |
| CN-105543013-B | Makeup removing soap of the liquid containing plant component extraction and preparation method thereof | 郑汉洙 | 2019-02-05 | — | — | CN | disclosed |
| CN-108785307-A | Composition containing procaterol hydrochloride and ambroxol hydrochloride | 沈涛 | 2018-11-13 | — | — | CN | disclosed |
| US-20180296565-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | HSU JOHN (US) | 2018-10-18 | — | — | US | disclosed |
| US-10004749-B2 | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | HSU JOHN (US) | 2018-06-26 | — | — | US | disclosed |
| EP-3324975-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | Hsu, John (US) | 2018-05-30 | — | — | EP | disclosed |
| WO-2018091048-A1 | ORAL DELIVERY VEHICLE | FERTIN PHARMA A/S (DK) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018091050-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2018-05-24 | — | — | WO | disclosed |
| US-20180140554-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2018-05-24 | — | — | US | disclosed |
| US-20180140591-A1 | ORAL DELIVERY VEHICLE CONTAINING NICOTINE | OKONO A/S (DK) | 2018-05-24 | — | — | US | disclosed |
| US-20180071277-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC (US) | 2018-03-15 | — | — | US | disclosed |
| WO-2018039749-A1 | P. SOMNIFERUM PLANTS FOR THE PRODUCTION OF CODEINE | TASMANIAN ALKALOIDS PTY LTD (AU) | 2018-03-08 | — | — | WO | disclosed |
| US-9884021-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2018-02-06 | — | — | US | disclosed |
| US-20170367975-A1 | PHARMACEUTICAL TABLET FOR USE IN ADMINISTERING ONE OR MORE PHARMACEUTICALLY ACTIVE INGREDIENTS | FERTIN PHARMA A/S (DK) | 2017-12-28 | — | — | US | disclosed |
| CN-107397738-A | A kind of compound medicament composition with function of relieving cough and calming asthma and application thereof | 佛山市第五人民医院 | 2017-11-28 | — | — | CN | disclosed |
| CN-107383032-A | For the morphine base of forensic science illicit drugs inspection, morphine hydrochloride, heroin hydrochloride standard substance method for preparing purified | 公安部物证鉴定中心 | 2017-11-24 | — | — | CN | disclosed |
| US-20170280647-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | TASMANIAN ALKALOIDS PTY LTD (AU) | 2017-10-05 | — | — | US | disclosed |
| CN-104897667-B | Application of Smith reagent in detecting GHB in liquid detection material | 公安部物证鉴定中心 | 2017-10-03 | — | — | CN | disclosed |
| US-20170239233-A1 | PHARMACEUTICAL TABLET FOR USE IN ADMINISTERING NICOTINE | FERTIN PHARMA A/S (DK) | 2017-08-24 | — | — | US | disclosed |
| US-9661865-B2 | Chewing gum comprising polyethylene | MONDELEZ UK HOLDINGS & SERVICES LIMITED (GB) | 2017-05-30 | — | — | US | disclosed |
| US-9648815-B2 | Papaver somniferum with high concentration of codeine | TASMANIAN ALKALOIDS PTY. LTD. (AU) | 2017-05-16 | — | — | US | disclosed |
| EP-1517616-B1 | COMPRESSED CHEWING GUM TABLET II | FERTIN PHARMA AS (DK) | 2017-03-01 | — | — | EP | disclosed |
| US-9565867-B2 | Confectionery product comprising low molecular weight polyvinyl acetate | GUMLINK A/S (DK) | 2017-02-14 | — | — | US | disclosed |
| WO-2017015309-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | HSU JOHN (US) | 2017-01-26 | — | — | WO | disclosed |
| US-20170020885-A1 | Composition Comprising a Therapeutic Agent and a Respiratory Stimulant and Methods for the Use Thereof | HSU JOHN (US) | 2017-01-26 | — | — | US | disclosed |
| CN-106265493-A | Improve the pharmaceutical composition of Codeine Hydrochloride drug injection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-106265493-A | Improve the pharmaceutical composition of Codeine Hydrochloride drug injection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-106265493-A | Improve the pharmaceutical composition of Codeine Hydrochloride drug injection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-106176588-A | Improve the preparation method of composition of Codeine Hydrochloride ejection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-106176588-A | Improve the preparation method of composition of Codeine Hydrochloride ejection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-106176588-A | Improve the preparation method of composition of Codeine Hydrochloride ejection preparation stability | 成都佳迪璐莎生物科技有限公司 | 2016-12-07 | — | — | CN | disclosed |
| US-9445612-B2 | Compressed chewing gum tablet | GUMLINK A/S (DK) | 2016-09-20 | — | — | US | disclosed |
| US-20160256396-A1 | Delayed Release Tablet With Defined Core Geometry | JAGOTEC AG (CH) | 2016-09-08 | — | — | US | disclosed |
| US-20160256454-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC | 2016-09-08 | — | — | US | disclosed |
| US-20160235086-A1 | Confectionery Product | FERTIN PHARMA A/S (DK) | 2016-08-18 | — | — | US | disclosed |
| CN-105543013-A | Makeup removing soap with plant botanical component extracting solution and manufacturing method for same | JUNG HAN-SOO | 2016-05-04 | — | — | CN | disclosed |
| US-9314424-B2 | Pastes for injection of a therapeutic agent | XERIS PHARMACEUTICALS, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| EP-1796483-B1 | TOFFEE GUM COMPRISING CHOCOLATE | GUMLINK AS (DK) | 2016-04-13 | — | — | EP | disclosed |
| US-9278076-B2 | Chronotherapeutic dosage forms | ENDO PHARMACEUTICALS INC. (US) | 2016-03-08 | — | — | US | disclosed |
| US-9186332-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2015-11-17 | — | — | US | disclosed |
| US-20150320686-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | GILIYAR CHANDRASHEKAR (US) | 2015-11-12 | — | — | US | disclosed |
| US-20150313847-A1 | Compressed Tablets | GUMLINK A/S (DK) | 2015-11-05 | — | — | US | disclosed |
| EP-2928681-A1 | COMPRESSED TABLETS | Gumlink A/S (DK) | 2015-10-14 | — | — | EP | disclosed |
| CN-104897667-A | Application of Smith reagent in detecting GHB in liquid detection material | INST FORENSIC SCIENCE MINISTRY PUBLIC SECURITY PRC | 2015-09-09 | — | — | CN | disclosed |
| US-9107921-B2 | Oral dosage forms for oxygen containing active agents and oxyl-containing polymers | SPRIASO LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-9066942-B2 | Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer | SPRIASO LLC (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150164835-A1 | Opioid Salts with Release Properties and Characteristics Useful for Abuse Deterrent Drug Product Formulations | PISGAH LABORATORIES, INC. | 2015-06-18 | — | — | US | disclosed |
| US-9040085-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2015-05-26 | — | — | US | disclosed |
| US-20150133664-A1 | CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF | UNIV TEXAS (US) | 2015-05-14 | — | — | US | disclosed |
| US-20150122279-A1 | Chewable Tablet Including Tobacco Powder | FERTIN PHARMA A/S (DK) | 2015-05-07 | — | — | US | disclosed |
| US-20150087666-A1 | ORAL DOSAGE FORMS FOR OXYGEN CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMERS | SPRIASO LLC | 2015-03-26 | — | — | US | disclosed |
| CN-103393768-B | Rhizoma Polygoni Cuspidati and Adenophora stricta combined medicine for cough relieving and panting calming, and preparation and application thereof | UNIV CHONGQING NORMAL | 2015-01-07 | — | — | CN | disclosed |
| US-20140378496-A1 | OPIOID ANALGESICS AND 3-HYDROXYACETANILIDE FOR TREATING PAIN | SLX PHARMACEUTICALS, LLC | 2014-12-25 | — | — | US | disclosed |
| US-20140363492-A1 | INTRACUTANEOUS INJECTION | XERIS PHARMACEUTICALS, INC. (US) | 2014-12-11 | — | — | US | disclosed |
| US-20140328912-A1 | Delayed Release Tablet With Defined Core Geometry | JAGOTEC AG (CH) | 2014-11-06 | — | — | US | disclosed |
| US-8858919-B2 | Method of providing fast relief to a user of a nicotine chewing gum | FERTIN PHARMA A/S (DK) | 2014-10-14 | — | — | US | disclosed |
| US-8828361-B2 | Tobacco alkaloid releasing chewing gum | FERTIN PHARMA A/S (DK) | 2014-09-09 | — | — | US | disclosed |
| US-20140227388-A1 | Compressed Chewing Gum Tablet | FERTIN PHARMA A/S (DK) | 2014-08-14 | — | — | US | disclosed |
| US-8790679-B2 | Intracutaneous paste composition | XERIS PHARMACEUTICALS, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-20140179728-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-20140179729-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC (US) | 2014-06-26 | — | — | US | disclosed |
| WO-2014086358-A1 | COMPRESSED TABLETS | GUMLINK A/S (DK) | 2014-06-12 | — | — | WO | disclosed |
| EP-1368005-B9 | CHRONOTHERAPEUTIC DOSAGE FORMS | ENDO PHARMACEUTICALS INC (US) | 2014-06-11 | — | — | EP | disclosed |
| US-8734763-B2 | Compressed chewing gum tablet | GUMLINK A/S (DK) | 2014-05-27 | — | — | US | disclosed |
| EP-1796484-B1 | CONFECTIONERY PRODUCT | GUMLINK AS (DK) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013184902-A1 | CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-12-12 | — | — | WO | disclosed |
| US-20130323184-A1 | Method Of Providing Fast Relief To A User Of A Nicotine Chewing Gum | FERTIN PHARMA A/S (DK) | 2013-12-05 | — | — | US | disclosed |
| US-20130309292-A1 | Tobacco Alkaloid Releasing Chewing Gum | FERTIN PHARMA A/S (DK) | 2013-11-21 | — | — | US | disclosed |
| CN-103393768-A | Rhizoma Polygoni Cuspidati and Adenophora stricta combined medicine for cough relieving and panting calming, and preparation and application thereof | UNIV CHONGQING NORMAL | 2013-11-20 | — | — | CN | disclosed |
| US-8574643-B2 | Transparent confectionery product | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2013-11-05 | — | — | US | disclosed |
| US-8541647-B2 | Papaver somniferum with high concentration of codeine | Tasmania Alkaloids Pty, Ltd. (AU) | 2013-09-24 | — | — | US | disclosed |
| US-8529875-B2 | Tobacco alkaloid releasing chewing gum | FERTIN PHARMA A/S (DK) | 2013-09-10 | — | — | US | disclosed |
| US-8524196-B2 | process involving a transfer of tobacco alkaloid from said chewing gum above a threshold transfer rate in the period of about 1/2 minute to about 2 1/2 minutes from initiation of said chewing process; maintained at a threshold transfer rate in an intermediate phase of the chewing process | FERTIN PHARMA A/S (DK) | 2013-09-03 | — | — | US | disclosed |
| EP-1368005-B1 | CHRONOTHERAPEUTIC DOSAGE FORMS | ENDO PHARMACEUTICALS INC (US) | 2013-08-21 | — | — | EP | disclosed |
| US-20130205452-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | TASMANIA ALKALOIDS PTY. LTD. (AU) | 2013-08-08 | — | — | US | disclosed |
| US-20130202735-A1 | Toffee Gum Comprising Chocolate | GUMLINK A/S (DK) | 2013-08-08 | — | — | US | disclosed |
| US-20130172381-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | SPRIASO LLC | 2013-07-04 | — | — | US | disclosed |
| US-8450365-B2 | Efficient synthesis of galanthamine | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130129640-A1 | Compressed Chewing Gum | GUMLINK A/S (DK) | 2013-05-23 | — | — | US | disclosed |
| WO-2013071089-A1 | OPIOID ANALGESICS AND 3-HYDROXYACETANILIDE FOR TREATING PAIN | SLX PHARMACEUTICALS, LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130122061-A1 | Delayed Release Tablet With Defined Core Geometry | JAGOTEC AG (CH) | 2013-05-16 | — | — | US | disclosed |
| US-8394407-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2013-03-12 | — | — | US | disclosed |
| WO-2013030726-A1 | PROGRAMMED DRUG DELIVERY | WOCKHARDT LIMITED (IN) | 2013-03-07 | — | — | WO | disclosed |
| CN-101253920-B | Compression chewingsweets tablet | GUMLINK AS | 2013-03-06 | — | — | CN | disclosed |
| US-8389008-B2 | coating comprising a natural or synthetic gum; releases a drug(s) into the colon after oral ingestion | PENWEST PHARMACEUTICALS CO. (US) | 2013-03-05 | — | — | US | disclosed |
| EP-2550969-A1 | METHOD OF DIAGNOSING ALLERGY OR HYPERSENSITIVITY TO OPIATES AND TO STRUCTURALLY RELATED COMPOUNDS. | Diater Laboratorios (ES) | 2013-01-30 | — | — | EP | disclosed |
| US-8362283-B2 | Cross-conjugated 2,5-cyclohexadienone and related synthesis methods | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-01-29 | — | — | US | disclosed |
| CN-101474148-B | Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof | Shenzhen zhijun pharmaceutical co ltd | 2012-11-14 | — | — | CN | disclosed |
| US-8309124-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2012-11-13 | — | — | US | disclosed |
| US-8293927-B2 | Efficient synthesis of morphine and codeine | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-10-23 | — | — | US | disclosed |
| EP-1931213-B1 | CHEWING GUM HAVING MODIFIED RELEASE | CADBURY HOLDINGS LTD (GB) | 2012-08-29 | — | — | EP | disclosed |
| EP-1817014-B1 | METHOD OF PROVIDING FAST RELIEF TO A USER OF A NICOTINE CHEWING GUM | FERTIN PHARMA AS (DK) | 2012-08-22 | — | — | EP | disclosed |
| EP-1589825-B2 | COMPRESSED CHEWING GUM TABLET | GUMLINK AS (DK) | 2012-08-01 | — | — | EP | disclosed |
| CN-101039587-B | Confectionery product | GUMLINK AS | 2012-07-18 | — | — | CN | disclosed |
| US-20120177734-A1 | Delayed Release Tablet with Defined Core Geometry | JAGOTEC AG (CH) | 2012-07-12 | — | — | US | disclosed |
| US-20120177739-A1 | Delayed Release Tablet with Defined Core Geometry | JAGOTEC AG (CH) | 2012-07-12 | — | — | US | disclosed |
| CN-102525993-A | Delayed release tablet with defined core geometry | JAGOTEC AG | 2012-07-04 | — | — | CN | disclosed |
| US-20120114789-A1 | Compressed Resin Moderated Chewing Gum | GUMLINK A/S (DK) | 2012-05-10 | — | — | US | disclosed |
| US-8168218-B2 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2012-05-01 | — | — | US | disclosed |
| US-8110209-B2 | Intracutaneous injection | XERIS PHARMACEUTICALS INC. (US) | 2012-02-07 | — | — | US | disclosed |
| EP-1761132-B1 | CHEWING GUM COMPRISING FLAVOR EMULSION | CADBURY HOLDINGS LTD (GB) | 2011-11-23 | — | — | EP | disclosed |
| CN-102223811-A | Chewing gum and methods of production thereof | CADBURY UK LTD | 2011-10-19 | — | — | CN | disclosed |
| CN-1984568-B | Compressed chewing gum tablet | GUMLINK AS | 2011-09-28 | — | — | CN | disclosed |
| CN-101972393-B | Fritillaria imperalis traditional Chinese medicine (TCM) composition for treating asthma and preparation method thereof | CHONGQING ACADEMY OF CHINESE MATERIA MEDICA | 2011-09-14 | — | — | CN | disclosed |
| US-20110217336-A1 | CHRONOTHERAPEUTIC DOSAGE FORMS AND METHODS OF TREATMENT USING CHRONOTHERAPY | SLATE PHARMACEUTICALS, LLC | 2011-09-08 | — | — | US | disclosed |
| EP-1796482-B1 | CONFECTIONERY PRODUCT | GUMLINK AS (DK) | 2011-07-13 | — | — | EP | disclosed |
| EP-1631251-B1 | DELAYED RELEASE TABLET WITH DEFINED CORE GEOMETRY | JAGOTEC AG (CH) | 2011-06-15 | — | — | EP | disclosed |
| US-20110111084-A1 | Chewing Gum and Gum Base Comprising Styrene-Isoprene-Styrene Copolymers | GUMLINK A/S (DK) | 2011-05-12 | — | — | US | disclosed |
| EP-2028951-B1 | CHEWING GUM COMPRISING A HYDROPHOBIC ENZYME FORMULATION | GUMLINK AS (DK) | 2011-04-27 | — | — | EP | disclosed |
| EP-2312933-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | Tasmanian Alkaloids Pty. Ltd. (AU) | 2011-04-27 | — | — | EP | disclosed |
| CN-101035437-B | Confectionery product | GUMLINK AS | 2011-03-30 | — | — | CN | disclosed |
| US-20110060310-A1 | INTRACUTANEOUS INJECTION | XERIS PHARMACEUTICALS, INC. | 2011-03-10 | — | — | US | disclosed |
| CN-101972393-A | Fritillaria imperalis traditional Chinese medicine (TCM) composition for treating asthma and preparation method thereof | CHONGQING ACADEMY OF CHINESE MATERIA MEDICA | 2011-02-16 | — | — | CN | disclosed |
| US-7887841-B2 | Multilayer, drug core, delay release gum compression coatings | ENDO PHARMACEUTICALS, INC. | 2011-02-15 | — | — | US | disclosed |
| WO-2010132570-A1 | SYNTHESIS OF MORPHINE AND RELATED DERIVATIVES | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20100292475-A1 | Efficient Synthesis Of Morphine And Codeine | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2010-11-18 | — | — | US | disclosed |
| US-20100292489-A1 | Cross-conjugated 2,5-cyclohexadienone and related synthesis methods | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2010-11-18 | — | — | US | disclosed |
| US-20100292466-A1 | Efficient Synthesis Of Galanthamine | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2010-11-18 | — | — | US | disclosed |
| CN-101035436-B | Toffee gum comprising chocolate | GUMLINK AS | 2010-09-29 | — | — | CN | disclosed |
| US-20100234600-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT | 2010-09-16 | — | — | US | disclosed |
| EP-2091347-B1 | CHEWING GUM COMPRISING POLYETHYLENE | CADBURY HOLDINGS LTD (GB) | 2010-09-08 | — | — | EP | disclosed |
| EP-1703802-B1 | COMPRESSED BIODEGRADABLE CHEWING GUM | GUMLINK AS (DK) | 2010-09-08 | — | — | EP | disclosed |
| EP-1827125-B1 | BIODEGRADABLE CHEWING GUM COMPRISING BIODEGRADABLE POLYMER WITH HIGH GLASS TRANSITION TEMPERATURE | GUMLINK AS (DK) | 2010-09-01 | — | — | EP | disclosed |
| EP-2203192-A1 | WOUND CARE FORMULATION | Northern Health And Social Care Trust (GB) | 2010-07-07 | — | — | EP | disclosed |
| US-20100159068-A1 | Confectionery Product | GUMLINK A/S (DK) | 2010-06-24 | — | — | US | disclosed |
| EP-1965655-B1 | CHEWING GUM AND GUM BASE COMPRISING STYRENE-ISOPRENE-STYRENE COPOLYMERS | GUMLINK AS (DK) | 2010-04-28 | — | — | EP | disclosed |
| EP-1830661-B1 | NON-TACK CHEWING GUM | GUMLINK AS (DK) | 2010-04-21 | — | — | EP | disclosed |
| EP-2172199-A1 | Sustained release tablet comprising pramipexole | Pharmacia Corporation (US) | 2010-04-07 | — | — | EP | disclosed |
| US-20090311368-A1 | Biodegradable toffee gum | GUMLINK A/S (DK) | 2009-12-17 | — | — | US | disclosed |
| US-20090304857-A1 | CHEWING GUM COMPRISING POLYETHYLENE | CADBURY HOLDINGS LIMITED (GB) | 2009-12-10 | — | — | US | disclosed |
| US-20090299265-A1 | Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same | TTI ELLEBEAU, INC. (JP) | 2009-12-03 | — | — | US | disclosed |
| WO-2009143574-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | TASMANIAN ALKALOIDS PTY LIMITED (AU) | 2009-12-03 | — | — | WO | disclosed |
| EP-1615626-B1 | TABLET WITH COLOURED CORE | JAGOTEC AG (CH) | 2009-10-14 | — | — | EP | disclosed |
| US-20090214698-A1 | Confectionery Product | GUMLINK A/S (DK) | 2009-08-27 | — | — | US | disclosed |
| EP-2091347-A1 | CHEWING GUM COMPRISING POLYETHYLENE | Cadbury Holdings Limited (GB) | 2009-08-26 | — | — | EP | disclosed |
| US-20090196834-A1 | Tobacco alkaloid releasing chewing gum | FERTIN PHARMA A/S (DK) | 2009-08-06 | — | — | US | disclosed |
| EP-1761243-B1 | TOBACCO ALKALOID RELEASING CHEWING GUM | FERTIN PHARMA AS (DK) | 2009-07-15 | — | — | EP | disclosed |
| CN-101474148-A | Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof | SHENZHEN ZHIJUN PHARMACEUTICAL (CN) | 2009-07-08 | — | — | CN | disclosed |
| US-20090169677-A1 | Chewing Gum Comprising a Hydrophobic Enzyme Formulation | GUMLINK A/S (DK) | 2009-07-02 | — | — | US | disclosed |
| US-20090169587-A1 | Chronotherapeutic dosage forms | PENWEST PHARMACEUTICALS CO. (US) | 2009-07-02 | — | — | US | disclosed |
| CN-100502677-C | Compressed chewing gum tablet | GUMLINK AS (DK) | 2009-06-24 | — | — | CN | disclosed |
| CN-101466273-A | Chewing gum containing hydrophobic enzyme preparation | GUMLINK AS (DK) | 2009-06-24 | — | — | CN | disclosed |
| US-20090143387-A1 | SUSTAINED-RELEASE TABLET COMPOSITION | PFIZER INC | 2009-06-04 | — | — | US | disclosed |
| CN-101432042-A | Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same | TTI ELLEBEAU INC (JP) | 2009-05-13 | — | — | CN | disclosed |
| US-20090098242-A1 | Transparent Confectionery Product | GUMLINK A/S (DK) | 2009-04-16 | — | — | US | disclosed |
| EP-1589826-B1 | COMPRESSED CHEWING GUM TABLET | GUMLINK AS (DK) | 2009-04-15 | — | — | EP | disclosed |
| EP-2043613-A1 | SOLID FORM | FMC CORPORATION (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2009037500-A1 | WOUND CARE FORMULATION | NORTHERN HEALTH AND SOCIAL CARE TRUST (GB) | 2009-03-26 | — | — | WO | disclosed |
| EP-2028951-A1 | CHEWING GUM COMPRISING A HYDROPHOBIC ENZYME FORMULATION | Gumlink A/S (DK) | 2009-03-04 | — | — | EP | disclosed |
| EP-1828279-B1 | DEGRADABLE POLYMER FOR CHEWING GUM | GUMLINK AS (DK) | 2009-02-18 | — | — | EP | disclosed |
| CN-100459873-C | Compressed chewing gum tablet II | GUMLINK AS (DK) | 2009-02-11 | — | — | CN | disclosed |
| US-20090022846-A1 | Chewing Gum Comprising Flavor Emulsion | MONDELEZ UK HOLDINGS & SERVICES LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| EP-2012595-A1 | TRANSPARENT CONFECTIONERY PRODUCT | Gumlink A/S (DK) | 2009-01-14 | — | — | EP | disclosed |
| WO-2009005613-A2 | STABLE NON-DISINTEGRATING DOSAGE FORMS AND METHOD OF MAKING SAME | BALCHEM CORPORATION (US) | 2009-01-08 | — | — | WO | disclosed |
| US-20090004285-A1 | Stable non-disintegrating dosage forms and method of making same | BALCHEM CORPORATION | 2009-01-01 | — | — | US | disclosed |
| EP-1765304-B1 | COMPRESSED CHEWING GUM TABLET | GUMLINK AS (DK) | 2008-12-24 | — | — | EP | disclosed |
| US-20080311162-A1 | Solid form | FMC CORPORATION | 2008-12-18 | — | — | US | disclosed |
| US-20080286343-A1 | Solid form | FMC CORPORATION | 2008-11-20 | — | — | US | disclosed |
| US-20080286409-A1 | Toffee Gum Comprising Chocolate | GUMLINK A/S (DK) | 2008-11-20 | — | — | US | disclosed |
| WO-2008140461-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | disclosed |
| WO-2008140459-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | disclosed |
| WO-2008140460-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080286344-A1 | Solid form | FMC CORPORATION | 2008-11-20 | — | — | US | disclosed |
| EP-1589825-B9 | COMPRESSED CHEWING GUM TABLET | GUMLINK AS (DK) | 2008-11-12 | — | — | EP | disclosed |
| US-20080260900-A1 | Degradable Polymer for Chewing Gum | GUMLINK A/S | 2008-10-23 | — | — | US | disclosed |
| US-20080260899-A1 | Chewing Gum Piece and Process for Making the Same | GUMLINK A/S (DK) | 2008-10-23 | — | — | US | disclosed |
| US-20080260901-A1 | Chewing Gum Having Modified Release | CADBURY HOLDINGS LIMITED (GB) | 2008-10-23 | — | — | US | disclosed |
| EP-1967234-A1 | Compressed chewing gum tablet | Gumlink A/S (DK) | 2008-09-10 | — | — | EP | disclosed |
| EP-1965655-A1 | CHEWING GUM AND GUM BASE COMPRISING STYRENE-ISOPRENE-STYRENE COPOLYMERS | Gumlink A/S (DK) | 2008-09-10 | — | — | EP | disclosed |
| CN-101253920-A | Compression chewingsweets tablet | GUMLINK AS (DK) | 2008-09-03 | — | — | CN | disclosed |
| US-7399858-B2 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof | MALLINCKRODT INC. (US) | 2008-07-15 | — | — | US | disclosed |
| US-20080166448-A1 | Biodegradable Chewing Gum Comprising Biodegradable Polymer with High Glass Transition Temperature | GUMLINK A/S (DK) | 2008-07-10 | — | — | US | disclosed |
| EP-1941929-A1 | ELECTRODE STRUCTURE FOR IONTOPHORESIS COMPRISING SHAPE MEMORY SEPARATOR, AND IONTOPHORESIS APPARATUS COMPRISING THE SAME | TTI ELLEBEAU, INC. (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1941928-A1 | ELECTRODE STRUCTURE FOR IONTOPHORESIS USED TO ADMINISTER DRUG ENCLOSED IN NANOPARTICLE AND IONTOPHORESIS DEVICE MAKING USE OF THE SAME | TTI ELLEBEAU, INC. (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1523241-B1 | COMPRESSED RESIN MODERATED CHEWING GUM | GUMLINK AS (DK) | 2008-07-02 | — | — | EP | disclosed |
| EP-1931213-A1 | CHEWING GUM HAVING MODIFIED RELEASE | CADBURY SCHWEPPES PLC (GB) | 2008-06-18 | — | — | EP | disclosed |
| US-20080124283-A1 | Method of Providing Fast Relief to a User of a Nicotine Chewing Gum | FERTIN PHARMA A/S (DK) | 2008-05-29 | — | — | US | disclosed |
| US-20080107770-A1 | Non-Tack Chewing Gum | GUMLINK A/S | 2008-05-08 | — | — | US | disclosed |
| CN-100381068-C | Resin-modified compressed chewing gum | GUMLINK AS (DK) | 2008-04-16 | — | — | CN | disclosed |
| WO-2008037251-A1 | CHEWING GUM COMPRISING POLYETHYLENE | CADBURY HOLDINGS LIMITED (GB) | 2008-04-03 | — | — | WO | disclosed |
| US-20080063609-A1 | Compressed chewing gum tablet | FERTIN PHARMA A/S (DK) | 2008-03-13 | — | — | US | disclosed |
| CN-100374035-C | Compressed chewing gum tablet | GUMLINK AS (DK) | 2008-03-12 | — | — | CN | disclosed |
| CN-100369607-C | Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method | SHENZHEN CITY PHARMACEUTICAL F (CN) | 2008-02-20 | — | — | CN | disclosed |
| EP-1885200-A1 | BIODEGRADABLE TOFFEE GUM | Gumlink A/S (DK) | 2008-02-13 | — | — | EP | disclosed |
| CN-100367869-C | Compressed chewing gum | GUMLINK AS (DK) | 2008-02-13 | — | — | CN | disclosed |
| CN-101119645-A | Chewing gum block and its production process | GUMLINK AS (DK) | 2008-02-06 | — | — | CN | disclosed |
| US-7323565-B2 | Using complex catalyst containing transition metal and phosphine | MALLINCKRODT INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-7321038-B2 | Method for the catalytic production of hydrocodone and hydromorphone | MALLINCKRODT INC. (US) | 2008-01-22 | — | — | US | disclosed |
| WO-2008008120-A1 | SOLID FORM | FMC CORPORATION (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20080014228-A1 | Solid form | FMC CORPORATION | 2008-01-17 | — | — | US | disclosed |
| EP-1871774-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE, HYDROMORPHONE, AND DERIVATIVES THEREOF | MALLINCKRODT, INC. (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007143989-A1 | CHEWING GUM COMPRISING A HYDROPHOBIC ENZYME FORMULATION | GUMLINK A/S (DK) | 2007-12-21 | — | — | WO | disclosed |
| US-20070292508-A1 | ORALLY DISINTEGRATING DOSAGE FORMS | BALCHEM CORPORATION (US) | 2007-12-20 | — | — | US | disclosed |
| CN-101090639-A | Biodegradable chewing gum comprising biodegradable polymer with high glass transition temperature | GUMLINK AS (DK) | 2007-12-19 | — | — | CN | disclosed |
| CN-101090638-A | Non-tack chewing gum | GUMLINK AS (DK) | 2007-12-19 | — | — | CN | disclosed |
| EP-1687310-B1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE AND HYDROMORPHONE | MALLINCKRODT INC (US) | 2007-12-12 | — | — | EP | disclosed |
| US-20070264388-A1 | Compressed Biodegradable Chewing Gum | GUMLINK A/S (DK) | 2007-11-15 | — | — | US | disclosed |
| WO-2007124744-A1 | TRANSPARENT CONFECTIONERY PRODUCT | GUMLINK A/S (DK) | 2007-11-08 | — | — | WO | disclosed |
| EP-1848283-A1 | CHEWING GUM PIECE AND PROCESS FOR MAKING THE SAME | Gumlink A/S (DK) | 2007-10-31 | — | — | EP | disclosed |
| EP-1562952-B1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE AND HYDROMORPHONE | MALLINCKRODT INC (US) | 2007-10-24 | — | — | EP | disclosed |
| CN-101039587-A | Confectionery product | GUMLINK AS (DK) | 2007-09-19 | — | — | CN | disclosed |
| EP-1830661-A1 | NON-TACK CHEWING GUM | Gumlink A/S (DK) | 2007-09-12 | — | — | EP | disclosed |
| CN-101035437-A | Confectionery product | GUMLINK AS (DK) | 2007-09-12 | — | — | CN | disclosed |
| CN-101035436-A | Toffee gum comprising chocolate | GUMLINK AS (DK) | 2007-09-12 | — | — | CN | disclosed |
| EP-1827125-A1 | BIODEGRADABLE CHEWING GUM COMPRISING BIODEGRADABLE POLYMER WITH HIGH GLASS TRANSITION TEMPERATURE | Gumlink A/S (DK) | 2007-09-05 | — | — | EP | disclosed |
| EP-1828279-A1 | DEGRADABLE POLYMER FOR CHEWING GUM | Gumlink A/S (DK) | 2007-09-05 | — | — | EP | disclosed |
| US-20070196481-A1 | Sustained-release tablet composition | PHARMACIA CORPORATION | 2007-08-23 | — | — | US | disclosed |
| EP-1817014-A1 | METHOD OF PROVIDING FAST RELIEF TO A USER OF A NICOTINE CHEWING GUM | Fertin Pharma A/S (DK) | 2007-08-15 | — | — | EP | disclosed |
| EP-1589825-B1 | COMPRESSED CHEWING GUM TABLET | GUMLINK AS (DK) | 2007-08-15 | — | — | EP | disclosed |
| US-20070166364-A1 | Transdermal Therapeutic System | BEIER CORNELIA | 2007-07-19 | — | — | US | disclosed |
| WO-2007076856-A1 | CHEWING GUM AND GUM BASE COMPRISING STYRENE-ISOPRENE-STYRENE COPOLYMERS | GUMLINK A/S (DK) | 2007-07-12 | — | — | WO | disclosed |
| US-20070148229-A1 | Tablet with coloured core | JAGOTEC AG (CH) | 2007-06-28 | — | — | US | disclosed |
| EP-1796483-A1 | TOFFEE GUM COMPRISING CHOCOLATE | Gumlink A/S (DK) | 2007-06-20 | — | — | EP | disclosed |
| EP-1796484-A1 | CONFECTIONERY PRODUCT | Gumlink A/S (DK) | 2007-06-20 | — | — | EP | disclosed |
| EP-1797769-A2 | Compressed chewing gum tablet | Gumlink A/S (DK) | 2007-06-20 | — | — | EP | disclosed |
| EP-1797770-A2 | Compressed chewing gum tablet | Gumlink A/S (DK) | 2007-06-20 | — | — | EP | disclosed |
| CN-1984568-A | Compressed chewing gum tablet | GUMLINK AS (DK) | 2007-06-20 | — | — | CN | disclosed |
| US-20070135754-A1 | ELECTRODE ASSEMBLY FOR IONTOPHORESIS FOR ADMINISTERING ACTIVE AGENT ENCLOSED IN NANOPARTICLE AND IONTOPHORESIS DEVICE USING THE SAME | TTI ELLEBEAU, INC. (JP) | 2007-06-14 | — | — | US | disclosed |
| US-7220473-B2 | Storage stability | HEXAL AG (DE) | 2007-05-22 | — | — | US | disclosed |
| US-20070110807-A1 | Delayed release tablet with defined core geometry | JAGOTEC AG (CH) | 2007-05-17 | — | — | US | disclosed |
| WO-2007038919-A1 | CHEWING GUM HAVING MODIFIED RELEASE | CADBURY SCHWEPPES PLC (GB) | 2007-04-12 | — | — | WO | disclosed |
| EP-1761132-A1 | CHEWING GUM COMPRISING FLAVOR EMULSION | Cadbury Schweppes Plc (GB) | 2007-03-14 | — | — | EP | disclosed |
| EP-1761243-A1 | TOBACCO ALKALOID RELEASING CHEWING GUM | Fertin Pharma A/S (DK) | 2007-03-14 | — | — | EP | disclosed |
| CN-1925752-A | Compressed biology degradable chewing-gum | GUMLINK AS (DK) | 2007-03-07 | — | — | CN | disclosed |
| US-20070021711-A1 | Iontophoresis device controlling administration amount and administration period of plurality of drugs | Transcutaneous Technologies, Inc. (JP) | 2007-01-25 | — | — | US | disclosed |
| EP-1517617-B1 | COMPRESSED CHEWING GUM | GUMLINK AS (DK) | 2007-01-17 | — | — | EP | disclosed |
| WO-2006116995-A1 | BIODEGRADABLE TOFFEE GUM | GUMLINK A/S (DK) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006104656-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE, HYDROMORPHONE, AND DERIVATIVES THEREOF | MALLINCKRODT INC. (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060211982-A1 | Intracutaneous injection | XERIS PHARMACEUTICALS, INC. | 2006-09-21 | — | — | US | disclosed |
| CN-1820752-A | Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method | SHENZHEN CITY PHARMACEUTICAL F (CN) | 2006-08-23 | — | — | CN | disclosed |
| EP-1687310-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE AND HYDROMORPHONE | Mallinckrodt Inc. (US) | 2006-08-09 | — | — | EP | disclosed |
| EP-1589901-A4 | INTRACUTANEOUS INJECTION | GENERIPHARM INC (US) | 2006-08-09 | — | — | EP | disclosed |
| CN-1816283-A | Compressed resin moderated chewing gum | SCANAVO AS (DK) | 2006-08-09 | — | — | CN | disclosed |
| WO-2006079338-A1 | CHEWING GUM PIECE AND PROCESS FOR MAKING THE SAME | GUMLINK A/S (DK) | 2006-08-03 | — | — | WO | disclosed |
| US-20060155130-A1 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof | MALLINCKRODT INC. | 2006-07-13 | — | — | US | disclosed |
| US-20060147580-A1 | Compressed chewing gum tablet | FERTIN PHARMA A/S (DK) | 2006-07-06 | — | — | US | disclosed |
| WO-2006066572-A2 | BIODEGRADABLE CHEWING GUM COMPRISING BIODEGRADABLE POLYMER WITH HIGH GLASS TRANSITION TEMPERATURE | GUMLINK A/S (DK) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066573-A1 | DEGRADABLE POLYMER FOR CHEWING GUM | GUMLINK A/S (DK) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066575-A1 | BIODEGRADABLE CHEWING GUM COMPRISING BIODEGRADABLE POLYMER WITH HIGH GLASS TRANSITION TEMPERATURE | GUMLINK A/S (DK) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066576-A1 | NON-TACK CHEWING GUM | GUMLINK A/S (DK) | 2006-06-29 | — | — | WO | disclosed |
| WO-2005047291-A9 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE AND HYDROMORPHONE | MALLINCKRODT INC (US) | 2006-06-22 | — | — | WO | disclosed |
| EP-1670442-A1 | DELAYED RELEASED DOSAGE FORMS | Penwest Pharmaceuticals Co. (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2006058536-A1 | METHOD OF PROVIDING FAST RELIEF TO A USER OF A NICOTINE CHEWING GUM | FERTIN PHARMA A/S (DK) | 2006-06-08 | — | — | WO | disclosed |
| EP-1663156-A2 | CHRONOTHERAPEUTIC DOSAGE FORMS | Penwest Pharmaceuticals Company (US) | 2006-06-07 | — | — | EP | disclosed |
| US-7056541-B1 | coated with a powder of a dried fruit or a dried herb natural vegetable flavoring agent | DANDY A/S (DK) | 2006-06-06 | — | — | US | disclosed |
| US-20060115433-A1 | Compressed chewing gum | GUMLINK A/S (DK) | 2006-06-01 | — | — | US | disclosed |
| CN-1777412-A | Sustained release tablet having defined core geometry | JAGOTEC AG (CH) | 2006-05-24 | — | — | CN | disclosed |
| WO-2006037343-A1 | CONFECTIONERY PRODUCT | GUMLINK A/S (DK) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037322-A1 | TOFFEE GUM COMPRISING CHOCOLATE | GUMLINK A/S (DK) | 2006-04-13 | — | — | WO | disclosed |
| US-20060074239-A1 | Method for the catalytic production of hydrocodone and hydromorphone | THERAKOS, INC. | 2006-04-06 | — | — | US | disclosed |
| US-20060051455-A1 | Compressed chewing gum tablet | GUMLINK A/S (DK) | 2006-03-09 | — | — | US | disclosed |
| EP-1631251-A1 | DELAYED RELEASE TABLET WITH DEFINED CORE GEOMETRY | JAGOTEC AG (CH) | 2006-03-08 | — | — | EP | disclosed |
| CN-1738539-A | Compressed chewing gum tablet | GUMLINK AS (DK) | 2006-02-22 | — | — | CN | disclosed |
| EP-1615626-A1 | TABLET WITH COLOURED CORE | JAGOTEC AG (CH) | 2006-01-18 | — | — | EP | disclosed |
| WO-2006003349-A1 | CHEWING GUM COMPRISING FLAVOR EMULSION | CADBURY SCHWEPPES PLC (GB) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006000232-A1 | TOBACCO ALKALOID RELEASING CHEWING GUM | FERTIN PHARMA A/S (DK) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000233-A1 | TOBACCO ALKALOID CONTAINING CHEWING GUM | FERTIN PHARMA A/S (DK) | 2006-01-05 | — | — | WO | disclosed |
| US-20060003050-A1 | Compressed chewing gum tablet II | GUMLINK A/S (DK) | 2006-01-05 | — | — | US | disclosed |
| CN-1713822-A | Resin-modified compressed chewing gum | GUMLINK AS (DK) | 2005-12-28 | — | — | CN | disclosed |
| US-20050276853-A1 | Chronotherapeutic dosage forms and methods of treatment using chronotherapy | ENDO PHARMACEUTICALS, INC. | 2005-12-15 | — | — | US | disclosed |
| WO-2005113557-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF HYDROCODONE AND HYDROMORPHONE | MALLINCKRODT, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| EP-1589826-A1 | COMPRESSED CHEWING GUM TABLET | Gumlink A/S (DK) | 2005-11-02 | — | — | EP | disclosed |
| EP-1589901-A2 | INTRACUTANEOUS INJECTION | Generipharm, Inc. (US) | 2005-11-02 | — | — | EP | disclosed |
| US-20050175733-A1 | Compressed resin moderated chewing gum | GUMLINK A/S (DK) | 2005-08-11 | — | — | US | disclosed |
| CN-1633241-A | Compressed chewing gum tablet II | GUMLINK AS (DK) | 2005-06-29 | — | — | CN | disclosed |
| CN-1633242-A | Compressed chewing gum | GUMLINK AS (DK) | 2005-06-29 | — | — | CN | disclosed |
| US-20050124811-A1 | Method for the catalytic production of hydrocodone and hydromorphone | LIEBEL-FLARSHEIM COMPANY LLC | 2005-06-09 | — | — | US | disclosed |
| EP-1536791-A1 | SUSTAINED-RELEASE TABLET COMPRISING REBOXETINE | Pharmacia Corporation (US) | 2005-06-08 | — | — | EP | disclosed |
| US-20050118267-A1 | Chronotherapeutic dosage forms | PENWEST PHARMACEUTICALS CO. (US) | 2005-06-02 | — | — | US | disclosed |
| US-20050112201-A1 | Delayed release dosage forms | PENWEST PHARMACEUTICALS CO. (US) | 2005-05-26 | — | — | US | disclosed |
| US-20050100632-A1 | Chewing gum core overcoated with active powder material such as antiseptic, cooling compound, flavor intensifier, sweetening or enzyme | STAHL BRONISLAW-JAN (DK) | 2005-05-12 | — | — | US | disclosed |
| US-6887999-B1 | Preparation of dihydrocodeine from codeine | ACURA PHARMACEUTICALS, INC. (US) | 2005-05-03 | — | — | US | disclosed |
| WO-2005027843-A2 | CHRONOTHERAPEUTIC DOSAGE FORMS | PENWEST PHARMACEUTICALS CO. (US) | 2005-03-31 | — | — | WO | disclosed |
| WO-2005027878-A1 | DELAYED RELEASED DOSAGE FORMS | PENWEST PHARMACEUTICALS CO. (US) | 2005-03-31 | — | — | WO | disclosed |
| EP-1517616-A1 | COMPRESSED CHEWING GUM TABLET II | Gumlink A/S (DK) | 2005-03-30 | — | — | EP | disclosed |
| EP-1517617-A1 | COMPRESSED CHEWING GUM | Gumlink A/S (DK) | 2005-03-30 | — | — | EP | disclosed |
| EP-1514477-A2 | A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in the coating | DANDY A/S (DK) | 2005-03-16 | — | — | EP | disclosed |
| US-20050048164-A1 | Chewing gum core overcoated with active powder materials containing anseptics, cooling compound, flavor intensifier, sweetening , enzyme, drug | STAHL BRONISLAW-JAN (DK) | 2005-03-03 | — | — | US | disclosed |
| WO-2005002566-A1 | ANTIPYRETIC MEDICINE CONTAINING DEXIBUPROFEN AS AN EFFECTIVE COMPONENT | AHN-GOOK PHARMACEUTICAL CO., LTD. (KR) | 2005-01-13 | — | — | WO | disclosed |
| EP-1495681-A2 | A coated chewing gum, a method for preparation thereof and the use of one or more active substances in the coating | DANDY A/S (DK) | 2005-01-12 | — | — | EP | disclosed |
| EP-1368005-A4 | CHRONOTHERAPEUTIC DOSAGE FORMS | PENWEST PHARMACEUTICALS CO (US) | 2004-12-01 | — | — | EP | disclosed |
| EP-1059848-B1 | A COATED CHEWING GUM, A METHOD FOR PREPARATION THEREOF AND THE USE OF ONE OR MORE ACTIVE SUBSTANCE(S) IN SOLID FORM | DANDY AS (DK) | 2004-11-17 | — | — | EP | disclosed |
| WO-2004093850-A1 | TABLET WITH COLOURED CORE | JAGOTEC AG (CH) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004093843-A1 | DELAYED RELEASE TABLET WITH DEFINED CORE GEOMETRY | JAGOTEC AG (CH) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004068965-A1 | COMPRESSED CHEWING GUM TABLET | GUMLINK A/S (DK) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004057959-A2 | INTRACUTANEOUS INJECTION | GENERIPHARM, INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| CN-1499960-A | Chornotherapeutic dosage forms | ����˹��ҩ�﹫˾ | 2004-05-26 | — | — | CN | disclosed |
| US-20040047901-A1 | Storage stability | HEXAL AG (DE) | 2004-03-11 | — | — | US | disclosed |
| US-20040028772-A1 | Method for preparation of chewing gum with customer acceptable taste | FERTIN PHARMA A/S (DK) | 2004-02-12 | — | — | US | disclosed |
| WO-2004010998-A1 | SUSTAINED-RELEASE TABLET COMPRISING REBOXETINE | PHARMACIA CORPORATION (US) | 2004-02-05 | — | — | WO | disclosed |
| WO-2004004478-A1 | COMPRESSED CHEWING GUM TABLET II | GUMLINK A/S (DK) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004004479-A1 | COMPRESSED CHEWING GUM | GUMLINK A/S (DK) | 2004-01-15 | — | — | WO | disclosed |
| EP-1368005-A2 | CHRONOTHERAPEUTIC DOSAGE FORMS | Penwest Pharmaceuticals Co. (US) | 2003-12-10 | — | — | EP | disclosed |
| CN-1130194-C | Solid pharmaceutical preparation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-12-10 | — | — | CN | disclosed |
| EP-1311240-A1 | METHOD FOR PREPARATION OF CHEWING GUM WITH CUSTOMER ACCEPTABLE TASTE | Fertin Pharma A/S (DK) | 2003-05-21 | — | — | EP | disclosed |
| US-20030082230-A1 | Chronotherapeutic dosage forms and methods of treatment using chronotherapy | PENWEST PHARMACEUTICALS COMPANY | 2003-05-01 | — | — | US | disclosed |
| WO-2002072034-A2 | CHRONOTHERAPEUTIC DOSAGE FORMS | PENWEST PHAMACEUTICALS CO. (US) | 2002-09-19 | — | — | WO | disclosed |
| EP-0845989-B1 | PAIN-ALLEVIATING DRUG COMPOSITION | UNIV VIRGINIA COMMONWEALTH (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2002013781-A1 | METHOD FOR PREPARATION OF CHEWING GUM WITH CUSTOMER ACCEPTABLE TASTE | FERTIN PHARMA A/S (DK) | 2002-02-21 | — | — | WO | disclosed |
| EP-1059848-A1 | A COATED CHEWING GUM, A METHOD FOR PREPARATION THEREOF AND THE USE OF ONE OR MORE ACTIVE SUBSTANCE(S) IN SOLID FORM | DANDY A/S (DK) | 2000-12-20 | — | — | EP | disclosed |
| CN-1257422-A | Solid pharmaceutical preparation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-06-21 | — | — | CN | disclosed |
| WO-2000025757-A1 | SUSTAINED RELEASE DELIVERY OF HIGHLY WATER-SOLUBLE COMPOUNDS | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | disclosed |
| CN-1251039-A | antitussive composition | DEZSO KORBONITS (AU) | 2000-04-19 | — | — | CN | disclosed |
| WO-2000020005-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING AN OPIATE ANALGESIC AND A SYNERGIZING SUBSTANCE | EGIS Gyógyszergyár Rt. (HU) | 2000-04-13 | — | — | WO | disclosed |
| WO-1999044436-A1 | A COATED CHEWING GUM, A METHOD FOR PREPARATION THEREOF AND THE USE OF ONE OR MORE ACTIVE SUBSTANCE(S) IN SOLID FORM | DANDY A/S (DK) | 1999-09-10 | — | — | WO | disclosed |
| US-5869498-A | ADMINISTERING A COMBINATION OF OXYCODONE, NAPROXEN AND A NONTOXIC N-METHYL-D-ASPARATATE (NMDA) RECEPTOR ANTAGONIST SUCH AS DEXTRORPHAN OR DEXTROMETHORPHAN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1999-02-09 | — | — | US | disclosed |
| US-5863922-A | AN ANALGESICS MIXTURE COMPRISING ACETAMINOPHEN, SEDATIVE BUTALBITAL AND A N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST SELECTED FROM DEXTRORPHAN, DEXTROMETHORPHAN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1999-01-26 | — | — | US | disclosed |
| US-5840731-A | COMPOSITION COMPRISING OPIOID ANALGESIC, ACETAMINOPHEN, NONTOXIC N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0845989-A2 | PAIN-ALLEVIATING DRUG COMPOSITION AND METHOD FOR ALLEVIATING PAIN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997004780-A2 | PAIN-ALLEVIATING DRUG COMPOSITION AND METHOD FOR ALLEVIATING PAIN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1997-02-13 | — | — | WO | disclosed |
| EP-0486563-B1 | CHEWING GUM COMPOSITION WITH ACCELERATED, CONTROLLED RELEASE OF ACTIVE AGENTS | FERTIN A/S (DK) | 1993-09-08 | — | — | EP | disclosed |
| CN-1061600-A | CHEMICAL PROCESS | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 1992-06-03 | — | — | CN | disclosed |
| EP-0193355-B1 | ANALGESIC COMPOSITION | ELI LILLY AND COMPANY (US) | 1992-04-01 | — | — | EP | disclosed |
| EP-0388125-A1 | Medicament | BEECHAM GROUP PLC (GB) | 1990-09-19 | — | — | EP | disclosed |
| US-4798792-A | STREPTOMYCES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-01-17 | — | — | US | disclosed |
| US-4576951-A | ANAGELSICS, NARCOTICS, ENKEPHALINS, POTENIATION | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1986-03-18 | — | — | US | disclosed |
| EP-0168658-A1 | Pyrrolecarboxylic acid derivative having analgesic activity, preparation thereof and compositions therefrom | POLI INDUSTRIA CHIMICA S.p.A. (IT) | 1986-01-22 | — | — | EP | disclosed |
| EP-0152542-A1 | Pyrrol-3-carboxylic acids having central analgesic activity | POLI INDUSTRIA CHIMICA S.p.A. (IT) | 1985-08-28 | — | — | EP | disclosed |
| EP-0152542-A1 | Pyrrol-3-carboxylic acids having central analgesic activity | POLI INDUSTRIA CHIMICA S.p.A. (IT) | 1985-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (34 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210000061-A1 | A Plant of Papaver Somniferum With An Altered Alkaloid Profile | ACHE, GUSB, POP1 | OPRD1 449/4885OPRM1 64/4885OPRK1 192/4885 |
| US-20150320686-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OPRM1 | OPRD1 8/4885OPRM1 3/4885OPRK1 5/4885 |
| US-20100292466-A1 | Efficient Synthesis Of Galanthamine | GALR2, GALR1, OPRK1 | OPRD1 21/4885OPRM1 4/4885OPRK1 3/4885 |
| US-20170020885-A1 | Composition Comprising a Therapeutic Agent and a Respiratory Stimulant and Methods for the Use Thereof | OPRM1, OPRL1, OPRK1 | OPRD1 5/4885OPRM1 1/4885OPRK1 3/4885 |
| US-20210244742-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | OPRM1, OPRL1, OPRK1 | OPRD1 5/4885OPRM1 1/4885OPRK1 3/4885 |
| US-20160256454-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OGFRL1 | OPRD1 6/4885OPRM1 4/4885OPRK1 5/4885 |
| US-20100292489-A1 | Cross-conjugated 2,5-cyclohexadienone and related synthesis methods | OPRK1, GALR2, OPRM1 | OPRD1 5/4885OPRM1 3/4885OPRK1 1/4885 |
| US-10791691-B2 | Papaver somniferum with high concentration of codeine | OPRM1, OPRK1, CPNE4 | OPRD1 12/4885OPRM1 1/4885OPRK1 2/4885 |
| US-20070196481-A1 | Sustained-release tablet composition | SI, ABCB11, SLC2A9 | OPRD1 1314/4885OPRM1 1791/4885OPRK1 1496/4885 |
| US-20140179728-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OPRM1 | OPRD1 8/4885OPRM1 3/4885OPRK1 5/4885 |
| US-20060155130-A1 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof | OPRM1, CYP2D6, CYP2B6 | OPRD1 18/4885OPRM1 1/4885OPRK1 11/4885 |
| US-20260144745-A1 | Sugar Free Soft Chew Tablets | SI, TREH, SLC2A3 | OPRD1 1740/4885OPRM1 1446/4885OPRK1 897/4885 |
| US-20180296565-A1 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | OPRM1, OPRL1, OPRK1 | OPRD1 5/4885OPRM1 1/4885OPRK1 3/4885 |
| US-20130172381-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OPRM1 | OPRD1 8/4885OPRM1 3/4885OPRK1 5/4885 |
| US-20190209551-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OGFRL1 | OPRD1 6/4885OPRM1 4/4885OPRK1 5/4885 |
| US-20150087666-A1 | ORAL DOSAGE FORMS FOR OXYGEN CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMERS | OGFR, OPRL1, OGFRL1 | OPRD1 7/4885OPRM1 4/4885OPRK1 5/4885 |
| US-20100292475-A1 | Efficient Synthesis Of Morphine And Codeine | OPRK1, OPRM1, OPRL1 | OPRD1 5/4885OPRM1 2/4885OPRK1 1/4885 |
| US-20110217336-A1 | CHRONOTHERAPEUTIC DOSAGE FORMS AND METHODS OF TREATMENT USING CHRONOTHERAPY | CRY1, CRH, PER2 | OPRD1 743/4885OPRM1 199/4885OPRK1 140/4885 |
| US-20150164835-A1 | Opioid Salts with Release Properties and Characteristics Useful for Abuse Deterrent Drug Product Formulations | OPRM1, OPRK1, OPRL1 | OPRD1 4/4885OPRM1 1/4885OPRK1 2/4885 |
| US-10004749-B2 | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | OPRM1, OPRL1, OPRK1 | OPRD1 5/4885OPRM1 1/4885OPRK1 3/4885 |
| US-20090143387-A1 | SUSTAINED-RELEASE TABLET COMPOSITION | SLC6A4, SLC6A2, CRH | OPRD1 122/4885OPRM1 216/4885OPRK1 63/4885 |
| US-20250213601-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES | ACE2, FURIN, SARS1 | OPRD1 3805/4885OPRM1 3809/4885OPRK1 3410/4885 |
| US-20170280647-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | OPRM1, OPRK1, CPNE4 | OPRD1 12/4885OPRM1 1/4885OPRK1 2/4885 |
| US-20140179729-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OPRM1 | OPRD1 8/4885OPRM1 3/4885OPRK1 5/4885 |
| US-20050124811-A1 | Method for the catalytic production of hydrocodone and hydromorphone | OPRM1, OPRK1, CYP3A5 | OPRD1 4/4885OPRM1 1/4885OPRK1 2/4885 |
| US-20100234600-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | OPRM1, OPRK1, POF1B | OPRD1 5/4885OPRM1 1/4885OPRK1 2/4885 |
| US-20130205452-A1 | PAPAVER SOMNIFERUM WITH HIGH CONCENTRATION OF CODEINE | OPRM1, OPRK1, POF1B | OPRD1 5/4885OPRM1 1/4885OPRK1 2/4885 |
| US-12551439-B2 | Flowpack for oral delivery of active ingredients | GCK, SLC2A8, SLC2A1 | OPRD1 1278/4885OPRM1 1490/4885OPRK1 746/4885 |
| US-20260144746-A1 | Protein Based Soft Chew Tablets | CARHSP1, HIRA, HEATR6 | OPRD1 2393/4885OPRM1 1937/4885OPRK1 1985/4885 |
| US-20180071277-A1 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | OGFR, OPRL1, OGFRL1 | OPRD1 6/4885OPRM1 4/4885OPRK1 5/4885 |
| US-20060074239-A1 | Method for the catalytic production of hydrocodone and hydromorphone | OPRM1, OPRK1, DOHH | OPRD1 4/4885OPRM1 1/4885OPRK1 2/4885 |
| US-20050276853-A1 | Chronotherapeutic dosage forms and methods of treatment using chronotherapy | CRY1, CRH, PER2 | OPRD1 743/4885OPRM1 199/4885OPRK1 140/4885 |
| US-20150133664-A1 | CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF | OPRK1, OPRM1, OPRD1 | OPRD1 3/4885OPRM1 2/4885OPRK1 1/4885 |
| US-10653700-B2 | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | OPRM1, OPRL1, OPRK1 | OPRD1 5/4885OPRM1 1/4885OPRK1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.